On Sunday at the Endocrine Society's Annual Meeting in Chicago, Danish biopharmaceutical company H. Lundbeck presented a result that endocrinologists tracking Cushing's disease drug development have ...
A once-daily pill that blocks a key adrenal receptor slashed androgen levels by 67% while allowing most patients to reduce their steroid doses to normal physiologic levels, Crinetics Pharmaceuticals ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results